The Food and Drug Administration has greenlit a new medicine to protect some of the people most at risk from Covid. The agency granted emergency use authorization for Pemgarda, a monoclonal antibody infusion, in immunocompromised people ages 12 and older. The drug is intended to protect against Covid for people who are not likely to… Continue reading F.D.A. Authorizes a New Covid Drug to Protect High-Risk People